DIGENE CORP
10-Q, EX-27, 2000-11-14
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: DIGENE CORP, 10-Q, EX-10.4, 2000-11-14
Next: AMERICA FIRST APARTMENT INVESTORS LP, 10-Q, 2000-11-14



<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          JUN-30-2001
<PERIOD-START>                             JUL-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                       9,511,327
<SECURITIES>                                11,115,774
<RECEIVABLES>                                4,282,660
<ALLOWANCES>                                   256,830
<INVENTORY>                                  4,956,569
<CURRENT-ASSETS>                            28,891,020
<PP&E>                                       7,298,304
<DEPRECIATION>                               4,268,263
<TOTAL-ASSETS>                              35,060,859
<CURRENT-LIABILITIES>                        5,099,305
<BONDS>                                              0
                                0
                                          0
<COMMON>                                       165,130
<OTHER-SE>                                  28,674,428
<TOTAL-LIABILITY-AND-EQUITY>                35,060,859
<SALES>                                      6,667,869
<TOTAL-REVENUES>                             7,172,016
<CGS>                                        2,911,863
<TOTAL-COSTS>                                5,017,514
<OTHER-EXPENSES>                                32,076
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 840
<INCOME-PRETAX>                            (1,825,111)
<INCOME-TAX>                                    90,401
<INCOME-CONTINUING>                        (1,915,512)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (1,915,512)
<EPS-BASIC>                                     (0.12)
<EPS-DILUTED>                                   (0.12)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission